At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 135 enrolled
Drug / intervention
DF277 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Parallel, Double-blind, Clinical Trial Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in Patients With Otic Eczema
In Brief
A Phase 3 clinical trial evaluating DF277 and Placebo for Otic Eczema. Completed, enrolled 135 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of DF277 for the treatment of otic eczema.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOtic Eczema
CountriesSpain
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
Primary CompletionMar 2012
Study CompletionMar 2013
First PostedNov 2013
TodayJul 2026
First PostedNov 27, 2013
Enrollment StartFeb 1, 2012
Primary CompletionMar 1, 2012
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.6 years ago
Interventions
DF277drug
Two administrations daily for 7 days
Placebodrug
Two administrations daily for 7 days